Next Article in Journal
Non-Proteinuric Diabetic Nephropathy
Next Article in Special Issue
Pork as a Source of Omega-3 (n-3) Fatty Acids
Previous Article in Journal
MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation
Article Menu

Export Article

Open AccessReview
J. Clin. Med. 2015, 4(9), 1753-1760; doi:10.3390/jcm4091753

Lipidomics to Assess Omega 3 Bioactivity

Department of Molecular Medicine, University of Padova, Via 8 Febbraio, 2-35122 Padova, Italy
Academic Editors: Lindsay Brown, Bernhard Rauch and Hemant Poudyal
Received: 15 June 2015 / Revised: 19 August 2015 / Accepted: 31 August 2015 / Published: 7 September 2015
(This article belongs to the Special Issue Omega-3 Fatty Acids in Health and Disease)
View Full-Text   |   Download PDF [54 KB, uploaded 7 September 2015]   |  

Abstract

How can we resolve the conflict between the strong epidemiological evidence pointing to the usefulness of fish—and, thus, omega 3—consumption with the debacle of supplementation trials? One potential explanation is that the null results obtained thus far are the consequences of ill-contrived investigations that do not allow us to conclude on the effects (or lack thereof) of omega 3 fatty acid supplementation. One potential solution is through the use of lipidomics, which should prove very useful to screen suitable patients and to correlate plasma (or red blood cells, or whole blood, or phospholipid) fatty acid profile with outcomes. This has never been done in omega 3 trials. The wise use of lipidomics should be essential part of future omega 3 trials and would help in untangling this current riddle. View Full-Text
Keywords: lipidomics; omega 3 fatty acids; lipid analysis; lipidome; cardiovascular disease; clinical trials lipidomics; omega 3 fatty acids; lipid analysis; lipidome; cardiovascular disease; clinical trials
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Visioli, F. Lipidomics to Assess Omega 3 Bioactivity. J. Clin. Med. 2015, 4, 1753-1760.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top